BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.84B
AUM Growth
+$450M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
28
New
Increased
Reduced
Closed

Top Buys

1
+$55.2M
2
+$41.9M
3
+$31.9M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$23.2M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M

Top Sells

1
+$25.8M
2
+$23.3M
3
+$22.7M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$21.3M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.92M

Sector Composition

1 Healthcare 86.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$308M 16.77%
3,998,542
-301,830
2
$270M 14.71%
7,202,585
-566,587
3
$228M 12.41%
3,627,714
-72,286
4
$182M 9.89%
4,763,270
-593,879
5
$106M 5.79%
1,404,445
6
$88M 4.79%
757,428
-20,698
7
$86.9M 4.73%
2,899,412
8
$67.9M 3.69%
3,689,071
+573,700
9
$60.9M 3.31%
5,516,322
-130,197
10
$55.8M 3.03%
3,275,816
+13,722
11
$55.2M 3%
+399,030
12
$45.3M 2.46%
714,602
+661,053
13
$42.4M 2.31%
339,870
-206,630
14
$36.3M 1.98%
1,102,311
15
$31.9M 1.74%
+102,000
16
$30.3M 1.65%
2,269,345
-70,000
17
$30.2M 1.64%
471,288
+16,488
18
$23.2M 1.26%
+381,886
19
$22.7M 1.23%
1,300,737
+210,909
20
$22.1M 1.2%
+1,950,148
21
$17.9M 0.97%
1,422,200
-24,500
22
$14.5M 0.79%
+373,300
23
$6.49M 0.35%
1,250,000
24
$5.37M 0.29%
1,779,340
+100,000
25
– –
-178,028
1
2